CISN - How Cancer is Studied - Biospecimen Issues: For Patients and Advocates
| You Are Here: Home > Cancer Research > How Cancer is Studied > Translational Research > Biospecimen Issues: For Patients and Advocates | |||||||||
Biospecimen Issues:
|
![]() |
Patients are generally willing to provide their tissue for research purposes. However, there are ethical, legal and logistical issues that complicate the process of obtaining patients' informed consent while maintaining their privacy. |
|
This is an area in which patients and advocates alike need to play a roll in. While researchers are focused on the science, advocates can help articulate the concerns many patients will have when asked to donate tissue. Many if not most patients would be happy, even proud, to donate tissue for research if their misgivings can be addressed.
| Section Index | |
| What We Know About Cancer | |
| ● | How Cancer is Studied |
| Drug Development | |
| New Treatments | |
| Research Advocacy | |
Following are areas of concern for biospecimen informed consent
The easier it is to link specimens to their donors, the greater the risk to donors' privacy and confidentiality. However, this also makes specimens more valuable to researchers because they contain outcome data. Thus, the policies and procedures established for the collection and distribution of specimens should reflect the level of risk and possible harm posed to donors. Under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, covered entities may use or disclose, without restriction, any health information that is de-identified by the removal of 18 specified identifiers enumerated in the Privacy Rule. Things you need to know before you give consent It is important for you to understand the issues below so you can balance any risk you may incur with the possible benefits for society.
|

